Argentina confirms first cases of highly mutated Covid variant PJ.2.1 as infant hospitalizations rise
“Posee mutaciones en su genoma que le confieren mayor afinidad con los receptores de nuestras células, lo que aumenta su transmisibilidad,” virologist Paola Resende told Clarín, according to Ellitoral.
The SARS-CoV-2 sublineage PJ.2.1, a descendant of JN.1 carrying 25 genetic changes from its predecessor, has been detected in Argentina for the first time, researchers at the National University of La Plata confirmed this week, according to Noticiasnet. The World Health Organization has placed the strain under monitoring as a “variant under surveillance” after its rapid spread in North America and Brazil.
Scientists at the university’s Public Health Laboratory, Genomic and Molecular Area sequenced three samples from patients hospitalized in Buenos Aires province hospitals and the city of Buenos Aires. Two were babies — one month and two months old — and the third was a 58-year-old adult, Clarín reported.
All three samples corresponded to PJ.2.1.
National surveillance data show Covid-19 now accounts for roughly one-third of respiratory viruses detected in infants under six months, with influenza and respiratory syncytial virus (RSV) making up the remaining two-thirds, according to Health Ministry records cited by Clarín and Diario San Rafael.
The 25 mutations constitute what researchers writing in the Journal of Infection classify as a “saltational variant” — a sudden evolutionary leap rather than gradual drift.
Resende, a member of the WHO Technical Advisory Group on Virus Evolution, said the changes increase the virus’s binding affinity for human cells, driving higher community transmissibility.
The WHO’s latest risk assessment states that clinical data remain insufficient to determine whether PJ.2.1 causes more severe disease than earlier Omicron subvariants.

Laboratory studies evaluated by the WHO found that sera from people vaccinated with updated formulations targeting the LP.8.1 and XFG variants — the latter nicknamed “Frankenstein” — effectively neutralize PJ.2.1, Clarín and Noticias Net reported. Argentina currently offers two vaccines: the mRNA formulation provided free at public vaccination centers and the domestically developed protein-subunit vaccine ARVAC, available in pharmacies.
Infants under six months cannot be vaccinated directly; they rely on antibodies transferred during pregnancy. The Latin American Vaccinology Society warned that Covid-19 booster coverage among pregnant women has fallen below 10 percent, even as RSV vaccination in the same group exceeds 80 percent, Noticias Net reported.
“Hay un aumento de casos leves, por ahora sin mayor gravedad en pediatría. En adultos pareciera ser algo de mayor gravedad,” said Eduardo López, head of the Department of Medicine at Ricardo Gutiérrez Children’s Hospital, speaking to Clarín. Pregnant women can receive the vaccine in any trimester to protect their newborns.
Founded as a provincial institution in 1897 and nationalized in 1905 under Joaquín V. González, the National University of La Plata grew from 573 students in its first eight years to more than 90,000 today. Its Public Health Laboratory, part of a research network that includes the La Plata Museum of Natural Sciences and the Astronomical Observatory, sequenced the three Argentine samples that confirmed local circulation of the PJ.2.1 variant.

Formosa province has reactivated PCR testing and swabbing in public hospitals and recommended mask use for health-care workers following what officials described as a sharp increase in cases, Diario San Rafael reported.
Related reading